𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pegylated liposomal doxorubicin treatment in recurrent gynecologic cancer patients with renal dysfunction

✍ Scribed by Yanfang Li; Kevin W. Finkel; Wei Hu; Siqing Fu; Jihong Liu; Robert Coleman; John J. Kavanagh


Book ID
113961091
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
163 KB
Volume
106
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Pegylated liposomal doxorubicin-efficacy
✍ Peter Hau; Klaus Fabel; Ulrike Baumgart; Petra RΓΌmmele; Oliver Grauer; Annekatri πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 215 KB

## Abstract ## BACKGROUND Doxorubicin exhibits high efficacy in malignant glioma cell cultures. Nonetheless, as a standard formulation, doxorubicin has not been used clinically, due to poor penetration of the blood‐brain barrier. Furthermore, doxorubicin is known to induce tumor resistance genes.